Our Work with Patient Groups
We recognize that individuals living with a given health condition are the ones who know best about the impact their disease has on their life, including the challenges and needs associated with it. One of the ways Pfizer works to ensure that we meet those needs is by working with patient groups who have a direct connection with the communities they represent.
Collaborating with Patient Group
This allows us to gain insights such as a better understanding of the burden of disease, gaps in care or information, barriers to accessing treatment and more, enabling us to focus our efforts on what truly matters to patients. Our work with patient groups typically takes the form of collaborations and/or arms-length financial support to drive initiatives focused on improving patient outcomes and/or health equity matters in areas of shared interest.
Pfizer values the essential role that patient groups play in the healthcare ecosystem. Based on mutual respect, our interactions with patient groups always adhere to high ethical standards and reflect the independence of the parties.
Pfizer ensures that relationships with patient organizations are conducted in strict compliance with relevant laws and regulations, industry codes, external standards and internal Pfizer policies and procedures.
Pfizer will only support and engage with patient groups who share the same strong commitment to ethics and integrity, have diverse sources of funding and who can confirm having appropriate governance in place to ensure independence of action.
Collaborating with Patient Group
There are numerous patient organizations in Canada that do important and meaningful work. As a result, the demand is too high to allow Pfizer to approve each request for support we receive. To help guide funding decisions, Pfizer prioritizes providing support to patient groups and projects that align with our current therapeutic areas of focus.
At Pfizer, we strongly believe that every person deserves to be seen, heard, and cared for. Other factors we consider when assessing funding requests are initiatives that support health equity and contribute to reducing healthcare disparities across the country.
COVID-19
C. difficile
Diabetes
Alopecia areata
Atopic dermatitis
Inflammatory bowel disease
Rheumatology (e.g., rheumatoid arthritis)
Iron Deficiency Anemia
Lyme disease
Migraine
Obesity
Breast cancer
Colorectal cancer
Genitourinary cancers (bladder, kidney, prostate)
Hematology (leukemia, multiple myeloma)
Lung cancer
Skin cancer (melanoma
Pneumococcal disease
Hemophilia
Sickle cell disease
Transthyretin amyloidosis cardiomyopathy (ATTR-CM)
Respiratory syncytial virus (RSV)
All requests for support must be made online.
Before initiating your request and making your submission, please review our application criteria and process.